Knight Therapeutics Inc. ranks on The Globe and Mail's fifth-annual Women Lead Here benchmark of executive gender diversity Pharmaceutical Investing
Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of Directors Psychedelics Investing
Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update Medical Device Investing
Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe aortic stenosis Medical Device Investing
Execution of Variation to Facility Agreement with PURE Asset Management, Company to Seek a Sale Transaction Biotech Investing
Goodness Growth Holdings Reschedules Fourth Quarter and Full Year 2023 Results Call to April 1, 2024 Psychedelics Investing
Seelos Therapeutics Provides Update on Top-Line Results from its Amyotrophic Lateral Sclerosis Study with SLS-005 Psychedelics Investing
